A detailed history of Acropolis Investment Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Acropolis Investment Management, LLC holds 460 shares of VRTX stock, worth $213,697. This represents 0.01% of its overall portfolio holdings.

Number of Shares
460
Previous 460 -0.0%
Holding current value
$213,697
Previous $213,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$392.81 - $485.53 $43,994 - $54,379
-112 Reduced 19.58%
460 $215,000
Q3 2023

Oct 11, 2023

BUY
$338.18 - $362.46 $193,438 - $207,327
572 New
572 $198,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Acropolis Investment Management, LLC Portfolio

Follow Acropolis Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acropolis Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acropolis Investment Management, LLC with notifications on news.